Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
28.1M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
141M
-
Shares change
-
-15.6M
-
Total reported value, excl. options
-
$37.2M
-
Value change
-
-$12.3M
-
Put/Call ratio
-
0.08
-
Number of buys
-
34
-
Number of sells
-
-46
-
Price
-
$0.26
Significant Holders of GeneDx Holdings Corp. - Class A Common Stock (WGS) as of Q4 2022
107 filings reported holding WGS - GeneDx Holdings Corp. - Class A Common Stock as of Q4 2022.
GeneDx Holdings Corp. - Class A Common Stock (WGS) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141M shares
.
Largest 10 shareholders include Blackstone Inc. (27.7M shares), Casdin Capital, LLC (16.4M shares), GOLDMAN SACHS GROUP INC (13.5M shares), BlackRock Inc. (12.8M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (10M shares), VANGUARD GROUP INC (9.34M shares), Corvex Management LP (9.15M shares), MARSHALL WACE, LLP (6.29M shares), GEODE CAPITAL MANAGEMENT, LLC (3.93M shares), and STATE STREET CORP (3.43M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.